Orthopedician Dr Vishal Beri takes charge Facility Director Fortis Mulund Kajal Rajput27 Oct 2023 9:05 AM GMTA seasoned healthcare professional, Dr Beri has over two decades of experience in healthcare. Dr Vishal Beri has held leadership positions with...
Amlitelimab shows promising results for Atopic Dermatitis Jacinthlyn Sylvia15 Oct 2023 2:30 PM GMTSanofi unveiled promising outcomes from its Phase 2b trial, STREAM-AD, during the European Academy of Dermatology and Venereology (EADV) 2023...
Asymptomatic malaria suppresses immune system and must be treated: Study Isra Zaman18 May 2022 1:45 PM GMTIt is commonly thought that asymptomatic malaria infections decrease the chances of severe disease. Rather, the disease suppresses the immune system...
High risk of serious blood clots until six months post covid-19 infection: BMJ Isra Zaman7 April 2022 5:00 PM GMTThere could be a high possibility of occurrence of deep vein thrombosis, pulmonary embolism, and bleeding event for up to 3 months, 6 months, and 2...
Berotralstat reduces overall disease burden in hereditary angioedema: Study Medical Dialogues Editorial Team8 March 2022 3:30 AM GMTUSA: In a new study conducted by Emel Aygoren-Pursun and team, it was found that berotralstat, regardless of baseline attack rate, is an effective...
Updated CPR guidance in accordance with new variants of Covid-19 amid evolving pandemic: AHA Medical Dialogues Editorial Team24 Feb 2022 3:30 AM GMTUSA: The American Heart Association's (AHA) recent update on cardiopulmonary resuscitation (CPR) for patients with suspected or confirmed COVID-19 now...
Molnupiravir harms offset stated benefits of the drug, reiterates ICMR Lalhmangaihkimi14 Jan 2022 10:22 AM GMTNew Delhi: The Indian Council of Medical Research (ICMR) is taking another strong stand against the antiviral drug, Molnupiravir for the treatment of...
Prophylaxis fitusiran may improve QoL and decrease bleeding in hemophilia patients: ATLAS-INH trial MD Editorial Team20 Dec 2021 3:30 AM GMTDelhi: The effectiveness of fitusiran 80 mg monthly subcutaneous prophylaxis in persons with hemophilia A or B with inhibitors was proven in Phase 3...
Tenapanor Monotherapy effectively treats hyperphosphatemia in dialysis patients: Study MD Editorial Team25 Oct 2021 3:30 AM GMTAccording to a recent study presented at the 58th European Renal Association-European Dialysis and Transplant Association meeting, tenapanor...
FDA panel approves First drug for Symptoms of Rare Liver Disease in children Dr. Shravani Dali22 July 2021 6:23 PM GMTRecently Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators announced that Bylvay (odevixibat),...
FDA Extends Approval of TRIKAFTA For Cystic Fibrosis Josepha James11 Jun 2021 3:30 AM GMTCystic fibrosis is caused by a defective protein that is the result of mutations in the CFTR gene. Although there is approximately 2,000 known cystic...
Low-Calorie Ketogenic Diet Rescues Obese Patients From Hypogonadism Dr Kartikeya Kohli9 Jun 2021 2:45 AM GMTLow levels of testosterone and sex hormone (SHBG) levels are often present in subjects with overweight and obesity. A recent study suggests that...
